GRMIX
Price
$28.61
Change
+$0.17 (+0.60%)
Updated
Jan 22 closing price
Net Assets
1.64B
VTSMX
Price
$146.29
Change
+$0.72 (+0.49%)
Updated
Jan 22 closing price
Net Assets
1.78T
Ad is loading...

GRMIX vs VTSMX

Header iconGRMIX vs VTSMX Comparison
Open Charts GRMIX vs VTSMXBanner chart's image
Nationwide S&P 500 Index R6
Price$28.61
Change+$0.17 (+0.60%)
VolumeN/A
Net Assets1.64B
Vanguard Total Stock Mkt Idx I
Price$146.29
Change+$0.72 (+0.49%)
VolumeN/A
Net Assets1.78T
GRMIX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GRMIX vs. VTSMX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRMIX is a Hold and VTSMX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.78T vs. GRMIX (1.64B). VTSMX pays higher dividends than GRMIX: VTSMX (1.26) vs GRMIX (1.20). GRMIX was incepted earlier than VTSMX: GRMIX (25 years) vs VTSMX (33 years). GRMIX is a more actively managed with annual turnover of: 5.76 vs. VTSMX (2.00). VTSMX has a lower initial minimum investment than GRMIX: VTSMX (3000) vs GRMIX (1000000). VTSMX (24.81) and GRMIX (24.44) have marching annual gain over last year. GRMIX (81.81) and VTSMX (80.56) have equivalent 5 years return.
GRMIXVTSMXGRMIX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years33 years-
Gain YTD3.5093.75294%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.64B1.78T0%
Annual Yield % from dividends1.201.2695%
Returns for 1 year24.4424.8199%
Returns for 3 years38.9536.40107%
Returns for 5 years81.8180.56102%
Returns for 10 years108.23194.8156%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSB30.810.67
+2.22%
Mesabi Trust
TOPS6.830.11
+1.70%
TOP Ships
KLAC771.914.67
+0.61%
KLA Corp
TVTX19.46N/A
N/A
Travere Therapeutics
BEP20.03-0.66
-3.19%
Brookfield Renewable Partners LP